Joost H. C. M. Kreijtz

Discovery Centre — Canada

Medicine · Health Sciences

32h-index3.4kcitations53works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(40), Respiratory viral infections research(20), Animal Disease Management and Epidemiology(17), Immune Response and Inflammation(16), Immune Cell Function and Interaction(10)

Publications53 total

1178 RIDE-001: a well-tolerated innate immunotherapy to treat cancer by targeting and reprogramming bone marrow progenitor cells
Regular and Young Investigator Award Abstracts·2025Open Access
Abstract 2236: A novel SIRPαxPD-L1 bispecific antibody remodels the innate and adaptive tumor microenvironment, and enhances tumor control
Cancer Research·2025
Targeting mTOR in myeloid cells prevents infection-associated inflammation
iScience·2025· 6 citedOpen Access
Epitope mapping of monoclonal antibodies: a comprehensive comparison of different technologies
mAbs·2023· 27 citedOpen Access
Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy
Journal for ImmunoTherapy of Cancer·2022· 16 citedOpen Access
P0379BION-1301, A FULLY BLOCKING ANTIBODY TARGETING APRIL FOR THE TREATMENT OF IGA NEPHROPATHY: ASSESSMENT OF SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS IN LONG-TERM NONCLINICAL STUDIES
Nephrology Dialysis Transplantation·2020· 1 citedOpen Access
Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint
Journal for ImmunoTherapy of Cancer·2019· 65 citedOpen Access
Blockade of ErbB2 and PD-L1 using a bispecific antibody to improve targeted anti-ErbB2 therapy
OncoImmunology·2019· 45 citedOpen Access
Abstract 1203: Preclinical development of ADU-1805, a highly selective pan-allele anti-SIRPα antibody that blocks the SIRPα-CD47 innate immune checkpoint
Tumor Biology·2019Open Access
Abstract 1203: Preclinical development of ADU-1805, a highly selective pan-allele anti-SIRPα antibody that blocks the SIRPα-CD47 innate immune checkpoint
Cancer Research·2019· 1 cited
Abstract 1702: Assessment of pharmacology and toxicology of anti-CTLA-4 antibody (ADU-1604) in non-human primates and evaluation of local anti-CTLA-4 application
Cancer Research·2018
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara–Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial
The Journal of Infectious Diseases·2018· 31 citedOpen Access
Differential Recognition of Influenza A Viruses by M1<sub>58–66</sub>Epitope-Specific CD8<sup>+</sup>T Cells Is Determined by Extraepitopic Amino Acid Residues
Journal of Virology·2015· 26 citedOpen Access
Heterosubtypic immunity to H7N9 influenza virus in isogenic guinea pigs after infection with pandemic H1N1 virus
Vaccine·2015· 6 citedOpen Access
Virus replication kinetics and pathogenesis of infection with H7N9 influenza virus in isogenic guinea pigs upon intratracheal inoculation
Vaccine·2015· 1 citedOpen Access
Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis
Vaccine·2015· 12 citedOpen Access
Induction of Influenza (H5N8) Antibodies by Modified Vaccinia Virus Ankara H5N1 Vaccine
Emerging infectious diseases·2015· 19 citedOpen Access
Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
The Lancet Infectious Diseases·2014· 93 cited
A Single Immunization With Modified Vaccinia Virus Ankara-Based Influenza Virus H7 Vaccine Affords Protection in the Influenza A(H7N9) Pneumonia Ferret Model
The Journal of Infectious Diseases·2014· 31 citedOpen Access
Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine
Vaccine·2014· 14 cited
page 1 of 3Next →

Frequent Co-authors

Guus F. Rimmelzwaan(37), Albert D. M. E. Osterhaus(34), Ron A. M. Fouchier(31), Geert van Amerongen(18), Rogier Bodewes(16), Thijs Kuiken(15), Gerd Sutter(13), Gerrie de Mutsert(11), Martina M. Geelhoed-Mieras(9), Judith M. A. van den Brand(8), Stella E. Vogelzang-van Trierum(7), Andrea van Elsas(7), Hans van Eenennaam(6), Peter van Run(5), Marine L. B. Hillaire(5), Nella J. Nieuwkoop(5), Yasemin Suezer(5), D. Lutje Hulsik(5), Carolien E. van de Sandt(4), Stella E. van Trierum(4)